scholarly journals Association of cyclophosphamide drug–metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors

2010 ◽  
Vol 94 (2) ◽  
pp. 645-654 ◽  
Author(s):  
H. Irene Su ◽  
Mary D. Sammel ◽  
Luke Velders ◽  
Michelle Horn ◽  
Corrie Stankiewicz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Ovarian Failure ◽  
Enzyme Polymorphisms ◽  
Drug Metabolizing Enzyme ◽  
Metabolizing Enzyme

Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors

2020 ◽  
pp. 1-6
Author(s):  
Lindsey M. Charo ◽  
Michael V. Homer ◽  
Loki Natarajan ◽  
Carolyn Haunschild ◽  
Karine Chung ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Ovarian Failure ◽  
Enzyme Polymorphisms ◽  
Young Breast Cancer

In Response to “Drug Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort”

2007 ◽  
Vol 25 (35) ◽  
pp. 5675-5677 ◽  
Author(s):  
Angela DeMichele ◽  
Phyllis Gimotty ◽  
Jeffrey Botbyl ◽  
Richard Aplenc ◽  
Theresa Colligon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Outcome ◽  
Node Positive ◽  
Enzyme Polymorphisms ◽  
Drug Metabolizing Enzyme ◽  
Breast Cancer Cohort ◽  
Metabolizing Enzyme ◽  
Positive Breast Cancer

scholarly journals Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors

2017 ◽  
Vol 24 (6) ◽  
pp. 663-668
Author(s):  
Michael V. Homer ◽  
Lindsey M. Charo ◽  
Loki Natarajan ◽  
Carolyn Haunschild ◽  
Karine Chung ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Genetic Variants ◽  
Breast Cancer Survivors ◽  
Ovarian Failure ◽  
Age At Menopause
Sign in / Sign up

Export Citation Format

Share Document